Search research articles
Contact Us
Filters
Showing results (1-10 of 140) with videos related to
Page
of 14
Sort By:
The Lancet. Neurology
|
July 10, 2003
The production and use of cells as therapeutic agents in neurodegenerative diseases
Ole Isacson
Brain Research Bulletin
|
May 29, 2002
Models of repair mechanisms for future treatment modalities of Parkinson's disease
Ole Isacson
Journal of Neurology
|
May 6, 2011
Functions of the nigrostriatal dopaminergic synapse and the use of neurotransplantation in Parkinson's disease
Alex Tsui, Ole Isacson
Trends in Neurosciences
|
November 30, 2016
The Threshold Theory for Parkinson's Disease
Simone Engelender, Ole Isacson
Expert Opinion on Biological Therapy
|
January 21, 2014
Advances in stem-cell--generated transplantation therapy for Parkinson's disease
Maria Sundberg, Ole Isacson
Cell Stem Cell
|
December 2, 2008
ALS model glia can mediate toxicity to motor neurons derived from human embryonic stem cells
Eva Hedlund, Ole Isacson
Experimental Neurology
|
May 5, 2005
Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice
Hyemyung Seo, Ole Isacson
Progress in Neurobiology
|
October 10, 2024
Neuronal threshold functions: Determining symptom onset in neurological disorders
Luc Jordi, Ole Isacson
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 16, 2004
Intrastriatal transforming growth factor alpha delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons
Oliver Cooper, Ole Isacson
Stem Cells (Dayton, Ohio)
|
July 15, 2006
Axonal growth regulation of fetal and embryonic stem cell-derived dopaminergic neurons by Netrin-1 and Slits
Ling Lin, Ole Isacson
Page
of 14
Search research articles
Search
Showing results (1-10 of 140) with videos related to
Sort By:
Page
of 14
The Lancet. Neurology
|
July 10, 2003
The production and use of cells as therapeutic agents in neurodegenerative diseases
Ole Isacson
Brain Research Bulletin
|
May 29, 2002
Models of repair mechanisms for future treatment modalities of Parkinson's disease
Ole Isacson
Journal of Neurology
|
May 6, 2011
Functions of the nigrostriatal dopaminergic synapse and the use of neurotransplantation in Parkinson's disease
Alex Tsui, Ole Isacson
Trends in Neurosciences
|
November 30, 2016
The Threshold Theory for Parkinson's Disease
Simone Engelender, Ole Isacson
Expert Opinion on Biological Therapy
|
January 21, 2014
Advances in stem-cell--generated transplantation therapy for Parkinson's disease
Maria Sundberg, Ole Isacson
Cell Stem Cell
|
December 2, 2008
ALS model glia can mediate toxicity to motor neurons derived from human embryonic stem cells
Eva Hedlund, Ole Isacson
Experimental Neurology
|
May 5, 2005
Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice
Hyemyung Seo, Ole Isacson
Progress in Neurobiology
|
October 10, 2024
Neuronal threshold functions: Determining symptom onset in neurological disorders
Luc Jordi, Ole Isacson
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 16, 2004
Intrastriatal transforming growth factor alpha delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons
Oliver Cooper, Ole Isacson
Stem Cells (Dayton, Ohio)
|
July 15, 2006
Axonal growth regulation of fetal and embryonic stem cell-derived dopaminergic neurons by Netrin-1 and Slits
Ling Lin, Ole Isacson
Page
of 14